| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308549 | Kidney International | 2005 | 8 Pages |
Abstract
These results, coupled with favorable toxicity profiles of pyridoxamine in humans, show promise for therapeutic use of pyridoxamine in primary hyperoxaluria and other kidney stone diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sergei V. Chetyrkin, Daniel Kim, John M. Belmont, J.O.N. I. Scheinman, Billy G. Hudson, Paul A. Voziyan,